US 11667890
Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion
granted A61KA61K2039/515A61K40/11
Quick answer
US patent 11667890 (Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion) held by Iovance Biotherapeutics, Inc. expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Iovance Biotherapeutics, Inc.
- Grant date
- Tue Jun 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/515, A61K40/11, A61K40/42, A61P